128 related articles for article (PubMed ID: 36413774)
1. Is the Urokinase Plasminogen Activator/Plasminogen Activator Inhibitor-1 Ratio a Marker of Sonographic Septations in Pleural Infection?
Yasuma T; D'Alessandro-Gabazza CN; Kobayashi T; Gabazza EC; Fujimoto H
Am J Respir Crit Care Med; 2023 Apr; 207(7):949. PubMed ID: 36413774
[No Abstract] [Full Text] [Related]
2. The Biological Role of Pleural Fluid PAI-1 and Sonographic Septations in Pleural Infection: Analysis of a Prospectively Collected Clinical Outcome Study.
Bedawi EO; Kanellakis NI; Corcoran JP; Zhao Y; Hassan M; Asciak R; Mercer RM; Sundaralingam A; Addala DN; Miller RF; Dong T; Condliffe AM; Rahman NM
Am J Respir Crit Care Med; 2023 Mar; 207(6):731-739. PubMed ID: 36191254
[No Abstract] [Full Text] [Related]
3. Biological effects of disruption of the tissue-type plasminogen activator, urokinase-type plasminogen activator, and plasminogen activator inhibitor-1 genes in mice.
Carmeliet P; Bouché A; De Clercq C; Janssen S; Pollefeyt S; Wyns S; Mulligan RC; Collen D
Ann N Y Acad Sci; 1995 Jan; 748():367-81; discussion 381-2. PubMed ID: 7695179
[No Abstract] [Full Text] [Related]
4. Tissue- and urokinase-type plasminogen activators and type 1 plasminogen activator inhibitor in melanomas and benign skin pigment neoplasms.
Gershtein ES; Medvedeva SV; Babkina IV; Kushlinskii NE; Trapeznikov NN
Bull Exp Biol Med; 2001 Jul; 132(1):670-4. PubMed ID: 11687850
[TBL] [Abstract][Full Text] [Related]
5. Urokinase and type I plasminogen activator inhibitor production by normal human hepatocytes: modulation by inflammatory agents.
Busso N; Nicodeme E; Chesne C; Guillouzo A; Belin D; Hyafil F
Hepatology; 1994 Jul; 20(1 Pt 1):186-90. PubMed ID: 8020888
[TBL] [Abstract][Full Text] [Related]
6. Oxygen modulates the release of urokinase and plasminogen activator inhibitor-1 by retinal pigment epithelial cells.
Erichsen JT; Jarvis-Evans J; Khaliq A; Boulton M
Int J Biochem Cell Biol; 2001 Mar; 33(3):237-47. PubMed ID: 11311855
[TBL] [Abstract][Full Text] [Related]
7. Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis.
Sier CF; Vloedgraven HJ; Ganesh S; Griffioen G; Quax PH; Verheijen JH; Dooijewaard G; Welvaart K; van de Velde CJ; Lamers CB
Gastroenterology; 1994 Nov; 107(5):1449-56. PubMed ID: 7926508
[TBL] [Abstract][Full Text] [Related]
8. The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review.
Tucker TA; Idell S
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535429
[TBL] [Abstract][Full Text] [Related]
9. Abnormal levels of urokinase plasminogen activator protein and tissue plasminogen activator activity in human aortic aneurysms.
Falkenberg M; Holmdahl L; Tjärnström J; Risberg B
Eur J Surg; 2001 Jan; 167(1):10-4. PubMed ID: 11213813
[TBL] [Abstract][Full Text] [Related]
10. Regulation and interactions in the activation of cell-associated plasminogen.
Myöhänen H; Vaheri A
Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
[TBL] [Abstract][Full Text] [Related]
11. Reduced tissue type plasminogen activator activity of the gastroduodenal mucosa in peptic ulcer disease.
Wodziński MA; Bardhan KD; Reilly JT; Cooper P; Preston FE
Gut; 1993 Oct; 34(10):1310-4. PubMed ID: 8244093
[TBL] [Abstract][Full Text] [Related]
12. Effects of platelet-derived growth factor isoforms on plasminogen activation by periodontal ligament and gingival fibroblasts.
Agis H; Bauer M; Knebl G; Watzek G; Gruber R
J Periodontal Res; 2008 Jun; 43(3):334-42. PubMed ID: 18447857
[TBL] [Abstract][Full Text] [Related]
13. Bispecific monoclonal antibodies increase the fibrin-specific fibrinolytic activity of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA).
Bos R; Nieuwenhuizen W
Ann N Y Acad Sci; 1992 Dec; 667():428-30. PubMed ID: 1309066
[No Abstract] [Full Text] [Related]
14. Diagnostic and prognostic values of plasma levels of fibrinolytic markers in gastric cancer.
Ho CH; Chao Y; Lee SD; Chau WK; Wu CW; Liu SM
Thromb Res; 1998 Jul; 91(1):23-7. PubMed ID: 9700849
[TBL] [Abstract][Full Text] [Related]
15. Retinal pigment epithelial cells secrete urokinase-type plasminogen activator and its inhibitor PAI-1.
Sirén V; Stephens RW; Salonen EM; Vaheri A; Summanen P; Immonen I
Ophthalmic Res; 1992; 24(4):203-12. PubMed ID: 1436981
[TBL] [Abstract][Full Text] [Related]
16. Regulation of intrapleural fibrinolysis by urokinase-alpha-macroglobulin complexes in tetracycline-induced pleural injury in rabbits.
Komissarov AA; Mazar AP; Koenig K; Kurdowska AK; Idell S
Am J Physiol Lung Cell Mol Physiol; 2009 Oct; 297(4):L568-77. PubMed ID: 19666776
[TBL] [Abstract][Full Text] [Related]
17. Blood and tissue fibrinolytic profiles in patients with colorectal carcinoma.
Montemurro P; Conese M; Altomare DF; Memeo V; Colucci M; Semeraro N
Int J Clin Lab Res; 1995; 25(4):195-200. PubMed ID: 8788547
[TBL] [Abstract][Full Text] [Related]
18. Cellular receptors for the plasminogen activators.
Bu G; Warshawsky I; Schwartz AL
Blood; 1994 Jun; 83(12):3427-36. PubMed ID: 8204869
[No Abstract] [Full Text] [Related]
19. Prognostic value of urokinase plasminogen activator and plasminogen activator inhibitor-1 in renal cell cancer.
Hofmann R; Lehmer A; Hartung R; Robrecht C; Buresch M; Grothe F
J Urol; 1996 Mar; 155(3):858-62. PubMed ID: 8583593
[TBL] [Abstract][Full Text] [Related]
20. Expression pattern of the urokinase-plasminogen activator system in rat DS-sarcoma: role of oxygenation status and tumour size.
Weinmann M; Thews O; Schroeder T; Vaupel P
Br J Cancer; 2002 Apr; 86(8):1355-61. PubMed ID: 11953898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
